Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer.
Saved in:
| Title: | Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer. |
|---|---|
| Authors: | Alshaebi F; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China., Safi M; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China., Algabri YA; Department of Biomedical Engineering, School of Control Science and Engineering, Shandong University, Jinan, Shandong, China., Al-Azab M; Department of Immunology, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, Guangzhou, China., Aldanakh A; Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Alradhi M; Department of Urology, The Affiliated Hospital of Qingdao Binhai University, Qingdao, Shandong, China., Reem A; Faculty of Medicine and Health Sciences, Amran University, Amran, Yemen., Zhang C; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China. |
| Source: | Frontiers in oncology [Front Oncol] 2023 Jan 31; Vol. 13, pp. 1099696. Date of Electronic Publication: 2023 Jan 31 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
